Jan 9 (Reuters) – Canada’s Valeant Pharmaceuticals
International Inc said its affiliate will sell its
Dendreon cancer business to China’s Sanpower Group Co Ltd
for $819.9 million, as the drugmaker…
The post UPDATE 1-Valeant to sell Dendreon unit to China’s Sanpower for $820 mln appeared first on NASDAQ.